As of Aug 23
| +0.03 / +0.20%|
The 3 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 20.00, with a high estimate of 21.00 and a low estimate of 17.00. The median estimate represents a +35.41% increase from the last price of 14.77.
The current consensus among 3 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.